145 related articles for article (PubMed ID: 38636673)
1. Development of a pharmaceutical database as an aid to the nonclinical detection of drug-induced cardiac toxicity.
De Alwis D; Foley CM; Herman E; Hill AP; Hoffmann PK; Kanda Y; Kaushik E; Pierson J; Puglisi R; Shi H; Yang X; Pugsley MK
J Pharmacol Toxicol Methods; 2024; 127():107507. PubMed ID: 38636673
[TBL] [Abstract][Full Text] [Related]
2. International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes.
Bass AS; Darpo B; Breidenbach A; Bruse K; Feldman HS; Garnes D; Hammond T; Haverkamp W; January C; Koerner J; Lawrence C; Leishman D; Roden D; Valentin JP; Vos MA; Zhou YY; Karluss T; Sager P
Br J Pharmacol; 2008 Aug; 154(7):1491-501. PubMed ID: 18663380
[TBL] [Abstract][Full Text] [Related]
3. A public-private consortium advances cardiac safety evaluation: achievements of the HESI Cardiac Safety Technical Committee.
Pierson JB; Berridge BR; Brooks MB; Dreher K; Koerner J; Schultze AE; Sarazan RD; Valentin JP; Vargas HM; Pettit SD
J Pharmacol Toxicol Methods; 2013; 68(1):7-12. PubMed ID: 23567075
[TBL] [Abstract][Full Text] [Related]
4. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.
Redfern WS; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Palethorpe S; Siegl PK; Strang I; Sullivan AT; Wallis R; Camm AJ; Hammond TG
Cardiovasc Res; 2003 Apr; 58(1):32-45. PubMed ID: 12667944
[TBL] [Abstract][Full Text] [Related]
5. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
Lawrence CL; Pollard CE; Hammond TG; Valentin JP
J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
[TBL] [Abstract][Full Text] [Related]
6. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc).
Chiang AY; Bass AS; Cooper MM; Engwall MJ; Menton RG; Thomas K
J Pharmacol Toxicol Methods; 2007; 56(2):95-102. PubMed ID: 17588780
[TBL] [Abstract][Full Text] [Related]
7. Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee.
Pierson JB; Berridge B; Blinova K; Brooks MB; Eldridge S; O'Brien CE; Pugsley MK; Schultze AE; Smith G; Stockbridge N; Valentin JP; Vicente J
J Pharmacol Toxicol Methods; 2024; 127():107511. PubMed ID: 38710237
[TBL] [Abstract][Full Text] [Related]
8. Safety pharmacology in focus: new methods developed in the light of the ICH S7B guidance document.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2006; 54(2):94-8. PubMed ID: 16806993
[TBL] [Abstract][Full Text] [Related]
9. The Challenges of Predicting Drug-Induced QTc Prolongation in Humans.
Valentin JP; Hoffmann P; Ortemann-Renon C; Koerner J; Pierson J; Gintant G; Willard J; Garnett C; Skinner M; Vargas HM; Wisialowski T; Pugsley MK
Toxicol Sci; 2022 Apr; 187(1):3-24. PubMed ID: 35148401
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Computational approaches to understand the adverse drug effect on potassium, sodium and calcium channels for predicting TdP cardiac arrhythmias.
Sharifi M
J Mol Graph Model; 2017 Sep; 76():152-160. PubMed ID: 28756335
[TBL] [Abstract][Full Text] [Related]
12. ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation.
Hanson LA; Bass AS; Gintant G; Mittelstadt S; Rampe D; Thomas K
J Pharmacol Toxicol Methods; 2006; 54(2):116-29. PubMed ID: 16843688
[TBL] [Abstract][Full Text] [Related]
13. Torsades de pointes liability inter-model comparisons: the experience of the QT PRODACT initiative.
Hashimoto K
Pharmacol Ther; 2008 Aug; 119(2):195-8. PubMed ID: 18486227
[TBL] [Abstract][Full Text] [Related]
14. Open-access database of literature derived drug-related Torsade de Pointes cases.
Krumpholz L; Wiśniowska B; Polak S
BMC Pharmacol Toxicol; 2022 Jan; 23(1):7. PubMed ID: 35012678
[TBL] [Abstract][Full Text] [Related]
15. A HESI consortium approach to assess the human predictive value of non-clinical repolarization assays.
Trepakova ES; Koerner J; Pettit SD; Valentin JP;
J Pharmacol Toxicol Methods; 2009; 60(1):45-50. PubMed ID: 19439186
[TBL] [Abstract][Full Text] [Related]
16. The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research.
Van Deuren B; Van Ammel K; Somers Y; Cools F; Straetemans R; van der Linde HJ; Gallacher DJ
J Pharmacol Toxicol Methods; 2009; 60(1):11-23. PubMed ID: 19422925
[TBL] [Abstract][Full Text] [Related]
17. Drug development and nonclinical to clinical translational databases: past and current efforts.
Monticello TM
Toxicol Pathol; 2015 Jan; 43(1):57-61. PubMed ID: 25389276
[TBL] [Abstract][Full Text] [Related]
18. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.
Pawson AJ; Sharman JL; Benson HE; Faccenda E; Alexander SP; Buneman OP; Davenport AP; McGrath JC; Peters JA; Southan C; Spedding M; Yu W; Harmar AJ;
Nucleic Acids Res; 2014 Jan; 42(Database issue):D1098-106. PubMed ID: 24234439
[TBL] [Abstract][Full Text] [Related]
19. Moving towards better predictors of drug-induced Torsade de Pointes. 2-3 November 2005, Crystal City, Virginia, USA.
Cavero I; Crumb W
Expert Opin Drug Saf; 2006 Mar; 5(2):335-40. PubMed ID: 16503753
[TBL] [Abstract][Full Text] [Related]
20. Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform.
Visone R; Lozano-Juan F; Marzorati S; Rivolta MW; Pesenti E; Redaelli A; Sassi R; Rasponi M; Occhetta P
Toxicol Sci; 2023 Jan; 191(1):47-60. PubMed ID: 36226800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
